Lemonaid Health Review: Sold Out of 23andMe's Bankruptcy for $10m - What That Means for Your Records
Back to Articles
Guides14 min readAugust 11, 2026

Lemonaid Health Review: Sold Out of 23andMe's Bankruptcy for $10m - What That Means for Your Records

Lemonaid Health is a national telehealth service licensed in all 50 states covering weight loss, mental health, sexual health and primary care, with GLP-1s from $129/mo. It was sold out of 23andMe's bankruptcy for $10 million in 2025.

By Med Consumer Watch Team
Lemonaid Health is a national US telehealth service based in San Francisco, offering online consultations and prescriptions across an unusually wide range: weight loss including compounded semaglutide and tirzepatide, mental health, sexual health, primary care, acne and skin, and chronic conditions including high blood pressure, migraine, hypothyroidism and cholesterol, plus at-home STD, A1C and blood type testing. Verified from its own pages: a clinical team of physicians, pharmacists, nurse practitioners and registered nurses, licensed in all 50 states, contactable on 888-536-2267, with GLP-1s advertised starting at $129/month and a give-$10-get-$10 referral. The thing a prospective patient most needs to know is not on the site. Lemonaid was acquired by 23andMe in 2021 for around $400 million. 23andMe filed for Chapter 11 bankruptcy on March 23, 2025. In September 2025, Lemonaid Health was sold for $10 million to Bambu Ventures in partnership with Innova Capital Partners. That is a change of ownership out of bankruptcy at roughly 2.5% of the previous valuation — and Lemonaid holds your medical records. This review contains affiliate links and we may earn a commission if you buy through them. The assessment is our own. Site details verified August 11, 2026; ownership history from published reporting on the 23andMe bankruptcy proceedings. Informational only — not medical advice.

The ownership change, and why it matters to a patient

This is not gossip about a company's finances. It bears directly on two things a patient should care about: continuity of care and what happens to health data. The sequence, as reported: 2021: 23andMe acquires Lemonaid Health for approximately $400 million. March 23, 2025: 23andMe files for Chapter 11 bankruptcy. September 2025: Lemonaid Health is acquired for $10 million by Bambu Ventures with Innova Capital Partners. 23andMe's direct-to-consumer genetic testing and research businesses ceased; the telehealth operation continued under new ownership. Why this matters for your data. The 23andMe bankruptcy became a national story precisely because of the health data question — what happens to sensitive personal health information when the company holding it is sold as an asset. Multiple state attorneys general issued public guidance to consumers about their data during those proceedings. Lemonaid is a telehealth provider holding medical records, prescription histories and, in the mental health line, therapy and psychiatric records. What to do about it, practically: Request and download a copy of your complete medical record. Under HIPAA you have a right of access to your records, and the provider must supply them, generally within 30 days. Do this now if you are an existing patient, and do it before you stop using any telehealth service. Read the current privacy policy, not the one you agreed to. Privacy terms can change under new ownership. Check specifically what is retained, for how long, and whether data is shared with or sold to third parties. Understand the distinction between HIPAA-covered and not. A telehealth provider delivering care is generally a HIPAA covered entity for that care, which is meaningful protection. Marketing data, app analytics and account information may sit outside it. Keep your own copy of prescriptions and test results, independent of any portal. On continuity of care. New ownership by a venture firm is not inherently bad — Bambu Ventures acquired the business to run it, not to wind it down, and 23andMe's telehealth arm was the part that survived. But a service that has just changed hands out of bankruptcy carries more operational uncertainty than an established, well-capitalised one, and that matters more for ongoing prescription care than for a one-off consultation. The practical rule: do not let any single telehealth provider be the only holder of your medical history. Have a local clinician, or at minimum your own downloaded records.
  • Date | Event | Relevance to patients
  • 2021 | 23andMe acquires Lemonaid for ~$400m | -
  • March 23, 2025 | 23andMe files Chapter 11 | Health data in bankruptcy became a national issue
  • September 2025 | Lemonaid sold for $10m to Bambu Ventures with Innova Capital | New owner; review current privacy terms
  • Now | Telehealth operations continue | Download your records; keep your own copies

If you use any telehealth service, download and keep your own copy of your complete medical record. You have a right of access under HIPAA. This matters most for services that have changed ownership, wound down, or been sold as part of insolvency proceedings - and it costs you nothing to do while the service is running.

What it treats, and the breadth question

The service range is genuinely wide, which is both its main selling point and the thing to think hardest about. Weight loss: compounded tirzepatide, compounded semaglutide, and a tirzepatide microdosing option, advertised from $129/month. Mental health: including ongoing progress tracking in the patient account. Sexual health: sildenafil, Viagra, and branded ED and libido products. Primary care: a "Primary Care Complete" offering and virtual doctor visits. Chronic conditions: high blood pressure, migraine, hypothyroidism, cholesterol. Skin: acne, dark spots. Testing: STD panel, A1C blood sugar, blood type. Where this model works well. For discrete, protocol-driven problems — a straightforward ED prescription, contraception, an acne regimen, an STD test — telehealth is faster, cheaper and less awkward than a clinic visit, and there is no clinical reason to sit in a waiting room for it. Being licensed in all 50 states with a mixed clinical team is a genuine operational strength. Where to be more careful. Chronic disease management by telehealth requires actual monitoring. Hypertension needs blood pressure readings, thyroid disease needs periodic TSH, cholesterol needs a lipid panel. Ask specifically how monitoring is handled, how often, and who reviews the results. A prescription renewal without monitoring is not management of the condition. Mental health care is not a prescription. Antidepressants work best alongside therapy for many conditions, and psychiatric medication requires follow-up, particularly in the first weeks when suicide risk can transiently increase in younger patients. Ask what the follow-up schedule is and how urgent concerns are handled out of hours. If you are in crisis, telehealth is not the route — call or text 988 in the US. Breadth has a trade-off. A service covering weight loss, psychiatry, ED, thyroid disease and dermatology is necessarily protocol-driven. That is efficient for simple problems and thin for complicated ones. The most important structural point: online-only care fragments your medical record. If your GLP-1 comes from one service, your antidepressant from another and your blood pressure medicine from your GP, nobody has the complete list — and interaction checking depends on someone having it. Tell every prescriber everything you take, including from telehealth and including supplements.

Ask any telehealth service how it handles monitoring before starting treatment for a chronic condition - how often bloods or readings are required, who reviews them, and what happens if they are abnormal. A service that renews prescriptions without monitoring is dispensing, not managing.

GLP-1s at $129 a month: what to check

Weight loss is the headline category and the compounded-medication rules apply here as everywhere. What is advertised: GLP-1s from $129/month, covering compounded tirzepatide, compounded semaglutide, and a tirzepatide microdosing option. The disclosures that matter: Compounded semaglutide and tirzepatide are not FDA-approved. They are not generics of Ozempic, Wegovy, Mounjaro or Zepbound — no generic of any of them exists — and they have not been shown to be therapeutically equivalent. FDA does not review compounded preparations for safety, effectiveness or manufacturing quality. The efficacy figures you have seen come from trials of the branded products at defined doses. They do not automatically transfer. Ask whether the price rises with your dose. GLP-1 dosing escalates by design, and dose-tiered pricing is the norm in this category — meaning the advertised entry price is frequently not what you pay by month four. Get the full dose-by-dose schedule in writing. Ask what "microdosing" means clinically. Sub-therapeutic GLP-1 dosing has no trial evidence; the published outcomes come from defined escalation to specific maintenance doses. Fewer side effects, yes — and correspondingly less of the effect you are paying for. Check the approved products first. LillyDirect and NovoCare Pharmacy offer manufacturer-direct self-pay pricing on the FDA-approved drugs, and commercial insurance can bring the cost down substantially further. For some patients the approved product now costs less than the compounded one, which is a reversal of the position two years ago and is not widely understood. Safety essentials, briefly. Do not use if you have a personal or family history of medullary thyroid carcinoma or MEN2. Not for use in pregnancy, breastfeeding, or when planning to conceive. Common effects are gastrointestinal and worst during escalation. Tell any anaesthetist you take a GLP-1 before a procedure — delayed gastric emptying matters. Absorption of oral medicines including oral contraceptives can be affected. Weight regain after stopping is the norm, so budget for this as long-term treatment.

Compounded GLP-1 medications are not FDA-approved and are not generic equivalents of the branded drugs. Do not use semaglutide or tirzepatide if you have a personal or family history of medullary thyroid carcinoma or MEN2, or if you are pregnant, breastfeeding or planning pregnancy. Check manufacturer-direct pricing for the FDA-approved products before committing.

Legitimacy, cost and what to establish before signing up

On legitimacy. Lemonaid states a clinical team of physicians, pharmacists, nurse practitioners and registered nurses licensed in all 50 states, publishes a phone number (888-536-2267) and a San Francisco base, and has operated at scale for years. Publishing a phone number and a physical location is a basic signal that a surprising number of telehealth services do not meet. Verify your own prescriber. Ask for their name and state licence number and check it on your state medical board's public register. This is your right and it takes two minutes. On cost, what to establish before entering a card: Whether the consultation fee is separate from the medication cost, and whether it recurs. Whether shipping is included. Whether the price changes with GLP-1 dose escalation — the single biggest source of unexpected cost in this category. Whether it is a subscription, how to cancel, and whether cancellation is self-service in the account. What insurance is accepted, if any, and whether a superbill is available for reimbursement. The refund position on unused medication or an unused period. Comparisons worth making: Against your own doctor. For chronic conditions, an in-person clinician who orders and reviews your bloods is doing something telehealth protocols generally do not. Against the manufacturer-direct GLP-1 programmes, for weight loss specifically. Against other telehealth services, on whether price is dose-flat or dose-tiered — this is where the largest differences hide. Against a pharmacy discount card, for generic medicines. Common generics for blood pressure, thyroid and cholesterol are often extremely cheap with a discount card, and a telehealth subscription for them may cost more than the drug. That last point deserves emphasis. Levothyroxine, most statins and most antihypertensives are inexpensive generics. If you are paying a monthly telehealth fee to be prescribed a $10 medication, the fee is the product — which is fine if the convenience is worth it to you, and worth knowing either way.

For chronic-condition generics such as thyroid, cholesterol and blood pressure medication, price the drug itself with a pharmacy discount card before subscribing. These are often very cheap generics, and the telehealth fee can exceed the cost of the medicine it prescribes.

Frequently asked questions

Is Lemonaid Health still operating? Yes. It was sold out of 23andMe's Chapter 11 bankruptcy in September 2025 to Bambu Ventures in partnership with Innova Capital Partners, for $10 million, and telehealth operations continued. Why does the ownership change matter? Because Lemonaid holds medical records, and the 23andMe bankruptcy raised significant public questions about health data in insolvency. Download your own records and read the current privacy policy. How do I get my medical records? Request them from the provider. Under HIPAA you have a right of access, generally fulfilled within 30 days. What does Lemonaid treat? Weight loss including compounded GLP-1s, mental health, sexual health, primary care, acne and skin, high blood pressure, migraine, hypothyroidism and cholesterol, plus at-home STD, A1C and blood type testing. Is it available in my state? The company states its medical team is licensed in all 50 states. Confirm for your specific treatment, as availability can vary by service. How much are the GLP-1s? Advertised from $129/month. Ask whether that price holds as your dose escalates — dose-tiered pricing is common in this category. Are the GLP-1s FDA-approved? The compounded versions are not. They are not generics and have not been shown to be therapeutically equivalent to the branded products. Is it cheaper than my doctor? For discrete problems, often. For chronic-condition generics, price the drug with a discount card first — the subscription can cost more than the medicine. Can I use insurance? Ask directly what is accepted and whether a superbill is available for reimbursement. What if I am in a mental health crisis? Do not rely on telehealth. In the US, call or text 988 for the Suicide and Crisis Lifeline, or go to an emergency department.

The Bottom Line

Our rating: 6.5 / 10. A capable, genuinely broad telehealth service with real operational strengths — and an ownership history a prospective patient should weigh before making it the custodian of their care. The strengths are real. A clinical team licensed in all 50 states, spanning physicians, pharmacists, nurse practitioners and nurses, covering an unusually wide set of conditions from weight loss and mental health to hypertension, thyroid and cholesterol, with at-home testing attached. A published phone number and a stated San Francisco base — basics that a surprising share of telehealth does not offer. For discrete, protocol-driven problems — contraception, ED, acne, an STD test — this model is faster, cheaper and less awkward than a clinic, and there is no clinical reason to prefer a waiting room. Two things to weigh. The ownership history is material: acquired by 23andMe for around $400 million in 2021, sold for $10 million out of Chapter 11 in September 2025 to Bambu Ventures with Innova Capital Partners. New ownership bought it to run it, and telehealth was the part of 23andMe that survived — but a business that has just changed hands out of insolvency carries more uncertainty than an established one, and that matters more for ongoing prescription care than for a one-off consultation. Given how prominently health data featured in those proceedings, download your complete medical record and read the current privacy policy — you have a right of access under HIPAA and it costs nothing. And the structural caution applies to all telehealth: chronic disease management requires monitoring, not just renewal. Ask how bloods and readings are handled and who reviews them. For chronic-condition generics, price the drug with a discount card first — the subscription can cost more than the medicine. Use it for discrete problems where speed and privacy matter. Keep a local clinician for anything ongoing, tell every prescriber everything you take, and hold your own copy of your records. Check Lemonaid Health's current services and pricing Informational only, not medical advice. Consult a licensed clinician before starting, stopping or changing any treatment. Site details verified August 11, 2026 and subject to change; ownership history from published reporting on the 23andMe Chapter 11 proceedings. Compounded medications are not FDA-approved, are not generic equivalents, and FDA does not review them for safety, effectiveness or manufacturing quality. Do not use GLP-1 medicines if you have a personal or family history of medullary thyroid carcinoma or MEN2, or if pregnant, breastfeeding or planning pregnancy. If you are in mental health crisis, call or text 988 in the US rather than using telehealth. Individual results vary and no outcome is guaranteed.

Medical Disclaimer

This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.

Enter to Win a $1,788 CoreAge Rx Gift Card

Enter for a chance to use it toward eligible CoreAge Rx products and services.

The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.

No purchase necessary. Prescription products require provider evaluation and approval. See Official Rules. Official Rules · Gift Card Terms · Privacy Policy · Terms